Johnson Lacey, Raynel Sarah, Seghatchian Jerard, Marks Denese C
Research and Development, The Australian Red Cross Blood Service, Sydney, NSW, Australia.
Research and Development, The Australian Red Cross Blood Service, Sydney, NSW, Australia.
Transfus Apher Sci. 2015 Oct;53(2):146-52. doi: 10.1016/j.transci.2015.10.011. Epub 2015 Oct 27.
Platelet concentrates can be cryopreserved in dimethylsulphoxide (DMSO) and stored at -80 °C, which increases the shelf-life from 5 days to up to 4 years. Cryopreserved platelets have been shown to contain a high number of microparticles that have in vitro haemostatic activity. Further, when transfused, cryopreserved platelets have been shown to be at least as haemostatically active, as liquid-stored platelets, if not more so. Given that microparticles are traditionally considered to be pro-coagulant, it is likely that their presence in the cryopreserved component contributes to this haemostatic effect. However, as microparticles are known to mediate many physiological and pathological processes, including in thrombosis and cancer development and progression, further work is warranted to fully understand the functional scope of the microparticles in cryopreserved platelets.
血小板浓缩物可在二甲基亚砜(DMSO)中冷冻保存,并在-80°C下储存,这将保质期从5天延长至长达4年。已证明冷冻保存的血小板含有大量具有体外止血活性的微粒。此外,在输注时,冷冻保存的血小板已被证明至少与液体储存的血小板具有相同的止血活性,甚至可能更强。鉴于微粒传统上被认为具有促凝血作用,它们在冷冻保存成分中的存在可能促成了这种止血效果。然而,由于已知微粒介导许多生理和病理过程,包括血栓形成以及癌症的发展和进展,因此有必要进一步开展工作以全面了解冷冻保存血小板中微粒的功能范围。